not the best bio prospect around that's for sure. With a bit of luck and some savvy marketing ALT could hit maybe 4c with a good Pericoach launch? Get the clinicians interested, because there's just no way any significant percentage of women will EVER buy/use the thing IMO. That's simply a fantasy.